James L. Kelley

1.4k total citations
73 papers, 1.1k citations indexed

About

James L. Kelley is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, James L. Kelley has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Organic Chemistry, 28 papers in Molecular Biology and 17 papers in Infectious Diseases. Recurrent topics in James L. Kelley's work include Synthesis and Characterization of Heterocyclic Compounds (15 papers), HIV/AIDS drug development and treatment (15 papers) and Synthesis and Biological Evaluation (12 papers). James L. Kelley is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (15 papers), HIV/AIDS drug development and treatment (15 papers) and Synthesis and Biological Evaluation (12 papers). James L. Kelley collaborates with scholars based in United States and United Kingdom. James L. Kelley's co-authors include Ed W. McLean, B. R. Baker, Barrett R. Cooper, Francis E. Soroko, F. E. SOROKO, Howard J. Schaeffer, David L. Musso, Richard G. Davis, J. W. T. Selway and Cecilia S. Koble and has published in prestigious journals such as Gastroenterology, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

James L. Kelley

70 papers receiving 1.0k citations

Peers

James L. Kelley
Soo S. Ko United States
Yvan Guindon Canada
Tove Tuntland United States
J. Castañer Spain
Steven R. Schow United States
William F. Huffman United States
I Hayakawa Japan
Marco L. Lolli Italy
Barbara Roth United States
Roderick J. Sorenson United States
Soo S. Ko United States
James L. Kelley
Citations per year, relative to James L. Kelley James L. Kelley (= 1×) peers Soo S. Ko

Countries citing papers authored by James L. Kelley

Since Specialization
Citations

This map shows the geographic impact of James L. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Kelley more than expected).

Fields of papers citing papers by James L. Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Kelley. The network helps show where James L. Kelley may publish in the future.

Co-authorship network of co-authors of James L. Kelley

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Kelley. A scholar is included among the top collaborators of James L. Kelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Kelley. James L. Kelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelley, James L., Debra Tristram, Masaki Yamada, & Charles Grose. (2015). Failure of a Single Varicella Vaccination to Protect Children With Cancer From Life-Threatening Breakthrough Varicella. The Pediatric Infectious Disease Journal. 34(9). 1027–1029. 10 indexed citations
2.
3.
Musso, David L., Felicia R. Cochran, James L. Kelley, et al.. (2002). Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity. Journal of Medicinal Chemistry. 46(3). 399–408. 55 indexed citations
4.
Orr, G. Faye, David L. Musso, James L. Kelley, et al.. (1997). Inhibition of Uridine Phosphorylase. Synthesis and Structure−Activity Relationships of Aryl-Substituted 1-((2-Hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil. Journal of Medicinal Chemistry. 40(8). 1179–1185. 7 indexed citations
5.
Kelley, James L., Ed W. McLean, Ronald C. Crouch, D R Averett, & Joel V. Tuttle. (1995). [[(Guaninylalkyl)phosphinico]methyl]phosphonic Acids. Multisubstrate Analog Inhibitors of Human Erythrocyte Purine Nucleoside Phosphorylase. Journal of Medicinal Chemistry. 38(6). 1005–1014. 30 indexed citations
6.
Kelley, James L., et al.. (1995). 8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity.. Journal of Medicinal Chemistry. 38(18). 3676–3679. 23 indexed citations
7.
Orr, G. Faye, David L. Musso, James L. Kelley, et al.. (1995). Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.. Journal of Medicinal Chemistry. 38(19). 3850–3856. 8 indexed citations
8.
9.
Kelley, James L., et al.. (1991). Synthesis and antirhinovirus activity of 8-substituted analogs of 6-(dimethylamino)-9-(4-methylbenzyl)-2-(trifluoromethyl)-9H-purine. Journal of Medicinal Chemistry. 34(1). 157–160. 13 indexed citations
10.
11.
Kelley, James L., Ed W. McLean, Mark Edelstein, et al.. (1990). Synthesis and biological activity of an acyclic analog of 5,6,7,8-tetrahydrofolic acid, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)propyl]amino]benzoyl]-L-glutamic acid. Journal of Medicinal Chemistry. 33(2). 561–567. 24 indexed citations
12.
Kelley, James L., et al.. (1990). Benzodiazepine receptor binding activity of 8-substituted-9-(3-substituted-benzyl)-6-(dimethylamino)-9H-purines. Journal of Medicinal Chemistry. 33(1). 196–202. 24 indexed citations
13.
Kelley, James L., Ed W. McLean, R M Ferris, & James L. Howard. (1990). Benzodiazepine receptor-binding activity of 9-(1-phenylethyl)purines. Journal of Medicinal Chemistry. 33(7). 1910–1914. 14 indexed citations
14.
Kelley, James L., Ed W. McLean, Robert M. Ferris, & James L. Howard. (1989). Benzodiazepine receptor binding activity of 6,9-disubstituted purines. Journal of Medicinal Chemistry. 32(5). 1020–1024. 20 indexed citations
15.
Kelley, James L., et al.. (1989). Synthesis and antirhinovirus activity of 6-(dimethylamino)-2-(trifluoromethyl)-9-(substituted benzyl)-9H-purines. Journal of Medicinal Chemistry. 32(8). 1757–1763. 23 indexed citations
16.
Kelley, James L., et al.. (1988). 9-(2-Fluorobenzyl)-6-(alkylamino)-9H-purines. A new class of anticonvulsant agents. Journal of Medicinal Chemistry. 31(5). 1005–1009. 16 indexed citations
17.
Kelley, James L., et al.. (1988). 6-(Alkylamino)-9-benzyl-9H-purines. A new class of anticonvulsant agents. Journal of Medicinal Chemistry. 31(3). 606–612. 32 indexed citations
18.
Kelley, James L., et al.. (1988). 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity. Journal of Medicinal Chemistry. 31(10). 2001–2004. 18 indexed citations
19.
Martindale, Robert G., et al.. (1987). Necrotizing Fasciitis as a Complication of Percutaneous Endoscopic Gastrostomy. Journal of Parenteral and Enteral Nutrition. 11(6). 583–585. 30 indexed citations
20.
Kelley, James L., J. W. T. Selway, & Howard J. Schaeffer. (1985). Purine Acyclic Nucleosides. 6-Dimethylamino-9-[(2-phenylalanylamido-1-substituted-ethoxy)methyl]purines as Candidate Antivirals. Journal of Pharmaceutical Sciences. 74(12). 1302–1304. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soo S. Ko Breakdown of academic impact, for papers by Yvan Guindon Breakdown of academic impact, for papers by Tove Tuntland Breakdown of academic impact, for papers by J. Castañer Breakdown of academic impact, for papers by Steven R. Schow Breakdown of academic impact, for papers by William F. Huffman Breakdown of academic impact, for papers by I Hayakawa Breakdown of academic impact, for papers by Marco L. Lolli Breakdown of academic impact, for papers by Barbara Roth Breakdown of academic impact, for papers by Roderick J. Sorenson
Rankless by CCL
2026